6,7-Dihydroimidazo[1,2-a]pyrazin-8(5H)-one, 97%, 250mg

Cyclohexaneacetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester, trans-, 95%, 1g

2,4-Dichloro-5-methylthieno[2,3-d]pyrimidine, 97.0%, 250mg

3-Furaldehyde, 97.0%, 25g

2-Chloro-4-nitrobenzotrifluoride, 98.0%, 5g

5,8-Dibromoquinoxaline, 95.0%, 10g

3,5-Dichloro-2-chloromethyl-pyridine; hydrochloride, 95.0%, 1g

2-Amino-5-(2,4-dimethyl-phenylcarbamoyl)-4-methyl-thiophene-3-carboxylic acid ethyl ester, 250mg

4-(4-Bromophenyl)morpholine>98.0%(GC)(T)25g

2,2-Dimethylethenylboronic acid, 95.0%, 25g

(6-Ethoxynaphthalen-2-yl)boronic acid, 95.0%, 5g

4-Fluoro-4'-hydroxy-3-methylbiphenyl, 95.0%, 5g

4-Fluoro-2-nitro-N-methylaniline, 98.0%, 100g